The former, however, explains RNA-world relics and linear chromosomes in eukaryotes, is consistent with Horiike and colleagues' results 1 and argues against an archaeal origin for the nucleus.

There’s a new kid on the block in the fast-growing radiopharmaceuticals category, as Nucleus RadioPharma chalks up an oversubscribed Series A that raised $56 million that will be used to create ...